Technologies available at this site
Non-GMP Manufacture: Light Path™ Discovery
GS Xceed® Gene Expression System
GS piggyBac® Transposon Technology
POTELLIGENT® CHOK1SV® Technology
Our Cambridge site has relocated to larger premises and now houses multiple modern preclinical research laboratories providing a wide range of early derisking services.
Our Early Development Services team focuses on a full risk assessment platform for in silico and in vitro services for developability, immunogenicity, stability, antibody humanization, protein engineering and provide non-GMP mammalian and microbial expression services.
Our protein experts can help optimize your drug candidate to give you the best chance for clinical success.